Predicta Med Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Predicta Med Ltd. - overview
Established
2020
Location
Tel Aviv, -, Israel
Primary Industry
Healthcare IT
About
Based in Tel Aviv, Israel, and founded in 2020 by Shlomit Steinberg-Koch CEO, and Benny Getz, CTO, Predicta Med Ltd. offers a decision support platform that enables early detection and treatment selection of undiagnosed diseases using its propriety AI engine. In February 2023, Predicta Med Ltd. raised venture funding from new investor CerraCap Ventures.
The company intends to employ its proprietary AI PredictAI™ (artificial intelligence) platform in autoimmune diseases. The platform collects, analyses, and enriches data-driven decision-making, assisting healthcare providers in reducing immune-related disease diagnoses for diseases such as Celiac, Crohn's Disease, Ulcerative Colitis, Multiple Sclerosis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Psoriatic Arthritis. The company intends to use the February 2023 funding to accelerate growth and expand its operations and business reach.
Current Investors
MassChallenge, ICONYClabs, Israel-Colorado Innovation Fund
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Analytics & Performance Software, Medical Software
Website
www.predicta-med.com
Verticals
Artificial Intelligence, Artificial Intelligence, Cloud Computing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Predicta Med Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.